NEW YORK (GenomeWeb News) – 23andMe today announced it has acquired CureTogether for an undisclosed amount.

Based in Mountain View, Calif., CureTogether is a community-based health site where members can share quantitative information about more than 500 medical conditions. The purchase is the first by 23andMe, which said that it provides the firm with "technology and talent that will improve 23andMe's ability to gather data for research, while also providing customers with engaging and meaningful interactions in 23andMe's online community."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.